Hypertensive Nephropathy

Nephrology
1
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

L
LabcorpNC - Burlington
1 program
1
ACE RenoPhase 41 trial
Active Trials
NCT07187713Recruiting300Est. Dec 2026
CH
Cardinal HealthOH - Dublin
1 program
PCSMPN/A1 trial
Active Trials
NCT04633993Completed70Est. Nov 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
LabcorpACE Reno
Cardinal HealthPCSMP

Clinical Trials (2)

Total enrollment: 370 patients across 2 trials

ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases

Start: Sep 2025Est. completion: Dec 2026300 patients
Phase 4Recruiting

Effectiveness of Implementation of a Patient-centered Self-management Program in Patients With Hypertensive Nephropathy

Start: Dec 2019Est. completion: Nov 202170 patients
N/ACompleted

Related Jobs in Nephrology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 370 patients
2 companies competing in this space